Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00682318 · ClinicalTrials.gov registry record · NA

Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

A NA study of Healthy, sponsored by Carsten Skarke, MD.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT00682318: Active NA study of Healthy, sponsored by Carsten Skarke, MD.

NCT00682318 is a NA study of Healthy that is active but no longer recruiting, run by Carsten Skarke, MD. The registered enrollment target is 40 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00682318, a NA study of Healthy, is active but no longer recruiting, sponsored by Carsten Skarke, MD.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The American Heart Association and the American College of Cardiology (AHA/ACC) recently encouraged "increased consumption of omega-3 fatty acids in the form of fish or capsule form (1 g/day) for risk reduction" and stated that "for treatment of elevated triglycerides, higher doses are usually necessary for risk reduction" (Smith SC et al. Circulation 2006;113:2363-72). These recommendations are based on conflicting evidence about the efficacy of the omega-3 treatment with data derived from single randomized trials or non-randomized studies (Smith SC et al. Circulation 2006;113:2363-72). Much effort has been undertaken to elucidate the role of omega-3 fatty acids in the development of cardiovascular disease, but even recent meta-analyses deliver no clear picture; they either favor (Mozaffarian D Jama 2006;296:1885-99) or reject (Hooper L Bmj 2006;332:752-60) the hypothesis of cardioprotective effects of omega-3 FAs. The objective of the clinical study is to study the effects of fish oil on blood and urinary markers of inflammation and cell stress. By using different permutations of high-dose supplementation of omega-3 and omega-6 fatty acids versus different alimentary omega-3 fish doses and grain alcohol versus different kinds of red wine, this trial will study how omega-3 fatty acids, ethanol and red wine constituents modulate biomarkers of inflammation and cell stress.

Conditions Studied

Healthy

Interventions

  • DRUG Fish Oil
  • DIETARY_SUPPLEMENT Safflower Oil
  • DIETARY_SUPPLEMENT Ethanol
  • DIETARY_SUPPLEMENT Omega-3 polyunsaturated fatty acids
  • DIETARY_SUPPLEMENT Omega-6 polyunsaturated fatty acid

Study Locations (1)

Pennsylvania

  • Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine - Philadelphia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2008-05
Est. Completion 2029-11
Phase NA

Sponsor

Carsten Skarke, MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00682318

The ClinicalTrials.gov registry entry for NCT00682318 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Carsten Skarke, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 5 interventions - of which Fish Oil is the first listed.

NCT00682318 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00682318 about?

NCT00682318 is a clinical study titled "Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers". The American Heart Association and the American College of Cardiology (AHA/ACC) recently encouraged "increased consumption of omega-3 fatty acids in the form of fish or capsule form (1 g/day) for risk reduction" and stated that "for treatment of elevated triglycerides, higher doses are usually neces...

What is the current status of trial NCT00682318?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2008-05. Estimated completion is 2029-11.

What conditions does trial NCT00682318 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00682318?

The interventions under investigation include: Fish Oil (DRUG), Safflower Oil (DIETARY_SUPPLEMENT), Ethanol (DIETARY_SUPPLEMENT), Omega-3 polyunsaturated fatty acids (DIETARY_SUPPLEMENT), Omega-6 polyunsaturated fatty acid (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00682318?

This trial is sponsored by Carsten Skarke, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00682318 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.